AAIPharma has acquired the Xcelodose 600S capsule filling system, enhancing the company’s preclinical and early phase clinical GMP supply capabilities. The Xcelodose 600S can accommodate batch sizes up to several thousand capsules in sizes from 00 to size 4 with a variety of fills including neat drug substance, granulations, and blends. Some of the benefits this technology provides include: decreased development time with clinical supplies available in less than three months; reduced active i...